ArticleJournal of atherosclerosis and thrombosis2026
Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study.
Takao Sato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.